首页> 外文期刊>Molecular pharmaceutics >Development of PDT/PET Theranostics: Synthesis and Biological Evaluation of an F-18-Radiolabeled Water-Soluble Porphyrin
【24h】

Development of PDT/PET Theranostics: Synthesis and Biological Evaluation of an F-18-Radiolabeled Water-Soluble Porphyrin

机译:PDT / PET治疗学的发展:F-18放射性标记的水溶性卟啉的合成和生物学评估

获取原文
获取原文并翻译 | 示例
           

摘要

Synthesis of the first water-soluble porphyrin radiolabeled with fluorine-18 is described: a new molecular theranostic agent which integrates the therapeutic selectivity of photodynamic therapy (PDT) with the imaging efficacy of positron emission tomography (PET). Generation of the theranostic was carried out through the conjugation of a cationic water-soluble porphyrin bearing an azide functionality to a fluorine-18 radiolabeled prosthetic bearing an alkyne functionality through click conjugation, with excellent yields obtained in both cold and hot synthesis. Biological evaluation of the synthesized structures shows the first example of an F-18-radiolabeled porphyrin retaining photo cytotoxicity following radiolabeling and demonstrable conjugate uptake and potential application as a radiotracer in vivo. The promising results gained from biological evaluation demonstrate the potential of this structure as a clinically relevant theranostic agent, offering exciting possibilities for the simultaneous imaging and photodynamic treatment of tumors.
机译:描述了第一个用氟18放射性标记的水溶性卟啉的合成:一种新型分子治疗剂,将光动力疗法(PDT)的治疗选择性与正电子发射断层扫描(PET)的成像功效相结合。通过将具有叠氮化物官能度的阳离子水溶性卟啉与通过点击缀合而具有炔烃官能度的氟-18放射性标记的假体缀合,从而实现了theranostic的合成,在冷合成和热合成中均获得了优异的收率。合成结构的生物学评估显示了F-18放射性标记的卟啉在放射性标记和可证明的结合物摄取后仍具有光细胞毒性并有可能在体内用作放射性示踪剂的第一个例子。从生物学评估中获得的有希望的结果证明了该结构作为临床相关治疗剂的潜力,为肿瘤的同时成像和光动力治疗提供了令人兴奋的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号